Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Prevalence, awareness, treatment and control of hypertension in employees of factories of Northern Greece: the Naoussa study

Journal of Human Hypertension volume 18, pages 623–629 (2004)Cite this article

Abstract

The objective of this study was to examine the prevalence and the levels of awareness, control, and treatment of hypertension in workers, technicians and clerks of factories of the city of Naoussa. A total of 1976 employees in 19 units were examined. From those, 1937 (1045 men and 892 women), 15–73 years of age, were included in the analysis. Every employee was examined twice with 1 week's interval between the two examinations. Analysis was performed using the 140/90 mmHg hypertension threshold. In every visit, three blood pressure (BP) measurements were taken with at least 1-min interval between them. In the analysis only the average BP of the second clinic visit was used. In total, hypertension prevalence was 30.5% (32.1% for men and 28.7% for women respectively, P=0.10). The levels of awareness, treatment, and control of hypertension in hypertensive patients were 18.6%, 11.8%, and 2.2%, respectively. The levels of awareness and treatment differed significantly between men and women (13.4 vs 25.4%, P<0.001 and 9.6 vs 14.8%, P<0.05), but there was no difference in the levels of control (1.5 vs 3.1%, P=0.18). Hypertension prevalence, awareness, and treatment differed also between patients <45 and ⩾45 years of age (22.0 vs 53.2%, P<0.001, 9.7 vs 28.4%, P<0.001 and 6.5 vs 17.7%, P<0.001, respectively). In conclusion, the prevalence of hypertension in our study's population is high, while the levels of awareness, treatment, and control are disappointing and should be significantly improved. There is also a difference in awareness and treatment in favour of women compared to men and in favour of patients ⩾45 years of age compared to those <45 years of age.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Whelton PK . Epidemiology of hypertension. Lancet 1994; 334: 101–106.

    Article  Google Scholar 

  2. MacMahon S et al. Blood pressure, stroke, and coronary heart disease, Part I: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765–774.

    Article  CAS  PubMed  Google Scholar 

  3. Stamler J, Stamler R, Neaton JD . Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med 1993; 153: 598–615.

    Article  CAS  PubMed  Google Scholar 

  4. Collins R et al. Blood pressure, stroke, and coronary heart disease, Part II: short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990; 335: 827–838.

    Article  CAS  PubMed  Google Scholar 

  5. MacMahon S, Rodgers A, Neal B, Chalmers J . Blood pressure lowering for the secondary prevention of myocardial infarction and stroke. Hypertension 1997; 29: 537–538.

    Article  CAS  PubMed  Google Scholar 

  6. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNCVI). Arch Intern Med 1997; 157: 2413–2446.

  7. Guidelines Subcommittee. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 17: 151–183.

  8. Burt VL et al. Prevalence of hypertension in the US adult population: results from the third National Health and Nutrition Examination Survey, 1988–1991. Hypertension 1995; 25: 305–313.

    Article  CAS  PubMed  Google Scholar 

  9. Joffres MR et al. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens 1997; 10: 1097–1102.

    Article  CAS  PubMed  Google Scholar 

  10. Colhoun HM, Dong W, Poulter NR . Blood pressure screening, management and control in England: results from the health survey for England 1994. J Hypertens 1998; 16: 747–752.

    Article  CAS  PubMed  Google Scholar 

  11. Tazi MA et al. Prevalence of the main cardiovascular risk factors in Morocco: results of a national survey, 2000. J Hypertens 2003; 21: 897–903.

    Article  CAS  PubMed  Google Scholar 

  12. De Henauw W et al. Trends in the prevalence, detection, treatment and control of arterial hypertension in the Belgian adult population. J Hypertens 1998; 16: 277–284.

    Article  CAS  PubMed  Google Scholar 

  13. Kastarinen MJ et al. Trends in blood pressure levels and control of hypertension in Finland from 1982 to 1997. J Hypertens 1998; 16: 1379–1387.

    Article  CAS  PubMed  Google Scholar 

  14. Marques-Vidal P et al. Sex differences in awareness and control of hypertension in France. J Hypertens 1997; 15: 1205–1210.

    Article  CAS  PubMed  Google Scholar 

  15. Wolf HK et al. Blood pressure levels in the 41 populations of the WHO MONICA project. J Hum Hypertens 1997; 11: 733–742.

    Article  CAS  PubMed  Google Scholar 

  16. Erdine S . How well is hypertension controlled in Europe? J Hypertens 2000; 18: 1348–1349.

    Article  CAS  PubMed  Google Scholar 

  17. Marques-Vidal P, Tuomilehto J . Hypertension awareness, treatment and control in the community: is the ‘rule of halves’ still valid? J Hum Hypertens 1997; 11: 212–220.

    Article  Google Scholar 

  18. Moulopoulos SD et al. Coronary heart disease risk factors in a random sample of Athenian adults: the Athens study. Am J Epidemiol 1987; 126: 882–892.

    Article  CAS  PubMed  Google Scholar 

  19. Stergiou GS, Thomopoulou GC, Skeva II, Mountokalakis TD . Prevalence, awareness, treatment, and control of hypertension in Greece: the Didima study. Am J Hypertens 1999; 12: 959–965.

    Article  CAS  PubMed  Google Scholar 

  20. Kissebah AH . Central obesity: measurement and metabolic effects. Diabetes Rev 1997; 5: 8–20.

    Google Scholar 

  21. American Society of Hypertension. Recommendations for routine blood pressure measurement by indirect cuff sphygmomanometry. Am J Hypertens 1992; 5: 207–209.

  22. Verdecchia P et al. White coat hypertension. Lancet 1996; 348: 1443–1445.

    Article  Google Scholar 

  23. La Batide-Alanore A et al. Comparison of nurse- and physician-determined clinic blood pressure levels in patients referred to a hypertension clinic. J Hypertens 2000; 18: 391–398.

    Article  CAS  PubMed  Google Scholar 

  24. Bovet P et al. Assessing the prevalence of hypertension in populations: are we doing it right? J Hypertens 2003; 21: 509–517.

    Article  CAS  PubMed  Google Scholar 

  25. Stergiou GS et al. Home or self blood pressure measurement? What is the correct term? J Hypertens 2003; 21: 2259–2264.

    Article  CAS  PubMed  Google Scholar 

  26. Pickering TG et al. Enviromental influences on blood pressure and the role of job strain. J Hypertens 1996; 14(Suppl): S179–S186.

    CAS  Google Scholar 

  27. Panagiotakos DB et al. Status and management of hypertension in Greece: role of the adoption of a Mediterranean diet: the Attica Study. J Hypertens 2003; 21: 1483–1489.

    Article  CAS  PubMed  Google Scholar 

  28. Wolf-Maier K et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada and the United States. JAMA 2003; 289: 2363–2369.

    Article  PubMed  Google Scholar 

  29. Durel L, Schneiderman N . Biobehavioral bases of hypertension in blacks. In: McCabe P, Schneiderman N, Field TF, Skyler JS (eds). Stress, Coping and Disease. Lawrence Erlbaum Associates Publishing: London, 1991, pp 3–33.

    Google Scholar 

Download references

Acknowledgements

We thank Mrs Olympia Karra, secretary of the Hypertension Unit of the 1st Department of Internal Medicine of Aristotle University for her work in preparing this paper.

Author information

Authors and Affiliations

  1. 1st Department of Internal Medicine, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece

    P A Sarafidis, A Lasaridis, S Gousopoulos, P Zebekakis, P Nikolaidis, I Tziolas & F Papoulidou

Authors
  1. P A Sarafidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Lasaridis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Gousopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P Zebekakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P Nikolaidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. I Tziolas
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F Papoulidou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P A Sarafidis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sarafidis, P., Lasaridis, A., Gousopoulos, S. et al. Prevalence, awareness, treatment and control of hypertension in employees of factories of Northern Greece: the Naoussa study. J Hum Hypertens 18, 623–629 (2004). https://doi.org/10.1038/sj.jhh.1001724

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001724

Keywords

This article is cited by

Search

Advanced search

Quick links